Prospective Randomized Controlled Multicentre Trial for Patients With Chronic Low Back Pain Comparing Disci/Rhus Toxicodendron Comp.®, Placebo and Waiting List Group (DISCI)

NCT00567736 Phase 3 COMPLETED

The aim of the study is to evaluate the efficacy of Disci/Rhus toxicodendron. comp.® in patients with chronic low back pain compared to waiting list group, or placebo.

Details

Lead sponsor	Charite University, Berlin, Germany
Phase	Phase 3
Status	COMPLETED
Enrolment	150
Start date	2007-08
Completion	2009-01

Conditions

• Chronic Low Back Pain

Interventions

• Disci/Rhus toxicodendron comp.®
• placebo solution

Primary outcomes

• Visual analogue scale (0-100 mm) low back pain — once after 8 weeks

Countries

Germany